Research output per year
Research output per year
Personal profile
Research interests
-ALS Clinical & Translational Research
-Clinical Correlates of Peripheral Nerve & Muscle Pathology
Clinical interests
Neuromuscular disorders, inpatient general neurology
Fingerprint
Dive into the research topics where Robert Bucelli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Protein kinetics of superoxide dismutase-1 in familial and sporadic amyotrophic lateral sclerosis
Ly, C. V., Ireland, M. D., Self, W. K., Bollinger, J., Jockel-Balsarotti, J., Herzog, H., Allred, P., Miller, L., Doyle, M., Anez-Bruzual, I., Trikamji, B., Hyman, T., Kung, T., Nicholson, K., Bucelli, R. C., Patterson, B. W., Bateman, R. J. & Miller, T., 2023, (Accepted/In press) In: Annals of Clinical and Translational Neurology.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-time quaking-induced conversion assays for prions: Applying a sensitive but imperfect test in clinical practice
Jones, S. M., Lazar, E. B., Porter, A. L., Prusinski, C. C., Brier, M. R., Bucelli, R. C. & Day, G. S., 2023, (Accepted/In press) In: European Journal of Neurology.Research output: Contribution to journal › Article › peer-review
-
Schwann cells and myelin in human peripheral nerve: Major protein components vary with age, axon size and pathology
Pestronk, A., Schmidt, R. E., Bucelli, R. & Sim, J., Apr 2023, In: Neuropathology and Applied Neurobiology. 49, 2, e12898.Research output: Contribution to journal › Article › peer-review
-
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study (Neurotherapeutics, (2022), 19, 4, (1248-1258), 10.1007/s13311-022-01237-4)
Benatar, M., Wuu, J., Andersen, P. M., Bucelli, R. C., Andrews, J. A., Otto, M., Farahany, N. A., Harrington, E. A., Chen, W., Mitchell, A. A., Ferguson, T., Chew, S., Gedney, L., Oakley, S., Heo, J., Chary, S., Fanning, L., Graham, D., Sun, P., Liu, Y., & 2 others, Sep 2022, In: Neurotherapeutics. 19, 5, p. 1686 1 p.Research output: Contribution to journal › Comment/debate
Open Access1 Scopus citations -
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
Benatar, M., Wuu, J., Andersen, P. M., Bucelli, R. C., Andrews, J. A., Otto, M., Farahany, N. A., Harrington, E. A., Chen, W., Mitchell, A. A., Ferguson, T., Chew, S., Gedney, L., Oakley, S., Heo, J., Chary, S., Fanning, L., Graham, D., Sun, P., Liu, Y., & 2 others, Jul 2022, In: Neurotherapeutics. 19, 4, p. 1248-1258 11 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations